Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Aug;62(2):314–318. doi: 10.1038/bjc.1990.285

Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital.

T S Ganesan 1, P F Wrigley 1, P A Murray 1, A G Stansfeld 1, A J d'Ardenne 1, S Arnott 1, A Jones 1, W S Shand 1, J S Malpas 1, T A Lister 1
PMCID: PMC1971829  PMID: 2386750

Abstract

One hundred and one consecutive patients with newly diagnosed stage I Hodgkin's disease (HD) received treatment at St Bartholomew's Hospital, between 1968 and 1987, with a median follow-up of 12 years. Eleven patients have been excluded from detailed analysis because they either received involved field radiotherapy (RT) or radiotherapy with chemotherapy or were lost to follow-up. Actuarial analysis predicts 78% to be alive and without relapse of Hodgkin's disease at 15 years. Ninety evaluable patients (clinical stage (CS) 24; pathological stage (PS) 66) received either mantle or inverted 'Y' RT and form the basis of this analysis. The median age was 33 years (63 men, 27 women). Histology at presentation was nodular sclerosing (39), lymphocytic predominant (27) or mixed cellularity (24). The presenting site was neck (78), axilla (6) groin (4) and mediastinum (2). Complete remission was achieved in all evaluable patients, the actuarial proportion in remission being 75% at 15 years. Factors predictive of a prolonged remission were pathological staging versus clinical staging (P = 0.02) and lymph node size less than 3 cm (P = 0.04). Actuarial overall survival in these 90 patients was 75% at 15 years and none of the above factors correlated with survival. Relapse of HD has occurred in 18 patients (5 within RT field, 10 without and 3 in both). Second remission was achieved in 15/18. The actuarial rate of second remission and survival was 40% at 10 years. Sixteen patients have died, 7 of Hodgkin's disease, 7 of unrelated causes and 2 of second malignancy. A further 3 patients who developed second malignancy are still alive. At 15 years the actuarial mortality related to HD was 12%. These results confirm the importance of long follow up to assess the efficacy of primary therapy.

Full text

PDF
314

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carde P., Burgers J. M., Henry-Amar M., Hayat M., Sizoo W., Van der Schueren E., Monconduit M., Noordijk E. M., Lustman-Marechal J., Tanguy A. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors. J Clin Oncol. 1988 Feb;6(2):239–252. doi: 10.1200/JCO.1988.6.2.239. [DOI] [PubMed] [Google Scholar]
  2. Cornbleet M. A., Vitolo U., Ultmann J. E., Golomb H. M., Oleske D., Griem M. L., Ferguson D. J., Miller J. B. Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980). J Clin Oncol. 1985 Jun;3(6):758–768. doi: 10.1200/JCO.1985.3.6.758. [DOI] [PubMed] [Google Scholar]
  3. Fuller L. M., Madoc-Jones H., Hagemeister F. B., Jr, Rodgers R. W., North L. B., Butler J. J., Martin R. G., Gamble J. F., Shullenberger C. C. Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin's disease patients: significance of mediastinal and non-mediastinal presentations. Int J Radiat Oncol Biol Phys. 1980 Jul;6(7):799–808. doi: 10.1016/0360-3016(80)90315-6. [DOI] [PubMed] [Google Scholar]
  4. Hagemeister F. B., Fuller L. M., Sullivan J. A., Johnston D., North L., Butler J. J., Velasquez W. S., Shullenberger C. C. Treatment of patients with stages I and II nonmediastinal Hodgkin's disease. Cancer. 1982 Dec 1;50(11):2307–2313. doi: 10.1002/1097-0142(19821201)50:11<2307::aid-cncr2820501115>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  5. Henry-Amar M. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. J Natl Cancer Inst. 1983 Nov;71(5):911–916. [PubMed] [Google Scholar]
  6. Hoppe R. T., Coleman C. N., Cox R. S., Rosenberg S. A., Kaplan H. S. The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood. 1982 Mar;59(3):455–465. [PubMed] [Google Scholar]
  7. KAPLAN H. S. The radical radiotherapy of regionally localized Hodgkin's disease. Radiology. 1962 Apr;78:553–561. doi: 10.1148/78.4.553. [DOI] [PubMed] [Google Scholar]
  8. Leibenhaut M. H., Hoppe R. T., Efron B., Halpern J., Nelsen T., Rosenberg S. A. Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol. 1989 Jan;7(1):81–91. doi: 10.1200/JCO.1989.7.1.81. [DOI] [PubMed] [Google Scholar]
  9. Mauch P., Tarbell N., Weinstein H., Silver B., Goffman T., Osteen R., Zajac A., Coleman C. N., Canellos G., Rosenthal D. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol. 1988 Oct;6(10):1576–1583. doi: 10.1200/JCO.1988.6.10.1576. [DOI] [PubMed] [Google Scholar]
  10. PETERS M. V., MIDDLEMISS K. C. A study of Hodgkin's disease treated by irradiation. Am J Roentgenol Radium Ther Nucl Med. 1958 Jan;79(1):114–121. [PubMed] [Google Scholar]
  11. Stoffel T. J., Cox J. D. Hodgkin's disease stage I and II. A comparison between two different treatment policies. Cancer. 1977 Jul;40(1):90–97. doi: 10.1002/1097-0142(197707)40:1<90::aid-cncr2820400117>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  12. Sutcliffe S. B., Gospodarowicz M. K., Bergsagel D. E., Bush R. S., Alison R. E., Bean H. A., Brown T. C., Chua T., Clark R. M., Curtis J. E. Prognostic groups for management of localized Hodgkin's disease. J Clin Oncol. 1985 Mar;3(3):393–401. doi: 10.1200/JCO.1985.3.3.393. [DOI] [PubMed] [Google Scholar]
  13. Timothy A. R., Sutcliffe S. B., Stansfeld A. G., Wrigley P. F., Jones A. E. Radiotherapy in the treatment of Hodgkin's disease. Br Med J. 1978 May 13;1(6122):1246–1249. doi: 10.1136/bmj.1.6122.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. van Leeuwen F. E., Somers R., Hart A. A. Splenectomy in Hodgkin's disease and second leukaemias. Lancet. 1987 Jul 25;2(8552):210–211. doi: 10.1016/s0140-6736(87)90782-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES